C 38 H 32 N 8 O 6 Zn 2 ,monoclinic, P12 1 /c1(no. 14), a =9.501(5) Å, b =18.589(5) Å, c =10.
Experimental details
H111 atom bound to N2 and H3B atom were found in difference Fouriermap andrefined freely.The other Hatoms were placed in calculated positionsand refinedinariding-model approximation with d(C-H)= 0.95 -0 .99Å ,d (O-H)=0 .83-0 .85Åa nd U iso (H) =1.2 U eq (C) or U iso (H) =1.5 U eq (O). The hydroxy group of 2,3-dihydroxybutanedioate is disordered (O3A, O3B) with occupation of 0.482(7):0.518(7).
Discussion
Bis-benzimidazoles are known to be strong chelating agents coordinating through both nitrogen atomsofthe C=N group [1] . The benzimidazole ring system is interesting being present in clinically approved anthelmintics, antiulcers, antivirals,and antihistamines [2] . Themoleculeofthe titlecomplex hasacrystallographiccenter of symmetry. Theasymmetric unit contains one of the zinc complex and the Zn(II) has adistorted tetrahedral coordination formed by one Oatoms from 2,3-dihydroxybutanedioate dianion and three Na toms (N1, N3, N4) from two 2,2'-(1,2-ethanediyl)bis(1H-benzimidazole) molecules. The bridging 2,3-dihydroxybutanedioate dianion and the intermolecular hydrogen bonds N-H···O i (symmetry code i: x-1,y,z)playveryimportant role in theformation, stability and crystallization of the title complex, assembling the molecules into atwo-dimensional network. 
